Weber F - Search Results

1

MR imaging and single-photon emission CT findings after gene therapy for human glioblastoma.

Floeth FW, Aulich A, Langen KJ, Burger KJ, Bock WJ, Weber F. Floeth FW, et al. Among authors: weber f. AJNR Am J Neuroradiol. 2001 Sep;22(8):1517-27. AJNR Am J Neuroradiol. 2001. PMID: 11559499 Free PMC article.

2

Tumor-free survival of 7 years after gene therapy for recurrent glioblastoma.

Floeth FW, Langen KJ, Reifenberger G, Weber F. Floeth FW, et al. Among authors: weber f. Neurology. 2003 Jul 22;61(2):270-1. doi: 10.1212/01.wnl.0000069926.27137.ef. Neurology. 2003. PMID: 12874421 No abstract available.

3

MRI characteristics and histological changes in glioblastoma after gene therapy.

Weber FW, Floeth FW, Reifenberger G, Felsberg J, Aulich A, Kiwit JC, Bock WJ. Weber FW, et al. Front Radiat Ther Oncol. 1999;33:244-52. doi: 10.1159/000061240. Front Radiat Ther Oncol. 1999. PMID: 10549494 Clinical Trial. No abstract available.

4

Local inflammation and devascularization--in vivo mechanisms of the "bystander effect" in VPC-mediated HSV-Tk/GCV gene therapy for human malignant glioma.

Floeth FW, Shand N, Bojar H, Prisack HB, Felsberg J, Neuen-Jacob E, Aulich A, Burger KJ, Bock WJ, Weber F. Floeth FW, et al. Among authors: weber f. Cancer Gene Ther. 2001 Nov;8(11):843-51. doi: 10.1038/sj.cgt.7700382. Cancer Gene Ther. 2001. PMID: 11773974 Clinical Trial.

5

Comparative follow-up of enhancement phenomena with MRI and Proton MR Spectroscopic Imaging after intralesional immunotherapy in glioblastoma--Report of two exceptional cases.

Floeth FW, Wittsack HJ, Engelbrecht V, Weber F. Floeth FW, et al. Among authors: weber f. Zentralbl Neurochir. 2002;63(1):23-8. doi: 10.1055/s-2002-31579. Zentralbl Neurochir. 2002. PMID: 12098080

6

Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy.

Floeth FW, Pauleit D, Wittsack HJ, Langen KJ, Reifenberger G, Hamacher K, Messing-Jünger M, Zilles K, Weber F, Stummer W, Steiger HJ, Woebker G, Müller HW, Coenen H, Sabel M. Floeth FW, et al. Among authors: weber f. J Neurosurg. 2005 Feb;102(2):318-27. doi: 10.3171/jns.2005.102.2.0318. J Neurosurg. 2005. PMID: 15739561

7

Gene Therapy for Treatment of Brain Tumors (HSV-tKIn Vivo Gene Transfer) : A Case Study.

Weber F, Floeth F, Bojar H. Weber F, et al. Methods Mol Med. 2000;35:499-509. doi: 10.1385/1-59259-086-1:499. Methods Mol Med. 2000. PMID: 21390826

8

3-[123I]Iodo-alpha-methyl-L-tyrosine uptake in cerebral gliomas: relationship to histological grading and prognosis.

Schmidt D, Gottwald U, Langen KJ, Weber F, Hertel A, Floeth F, Felsberg J, Reifenberger G, Coenen HH, Müller-Gärtner HW. Schmidt D, et al. Among authors: weber f. Eur J Nucl Med. 2001 Jul;28(7):855-61. doi: 10.1007/s002590100553. Eur J Nucl Med. 2001. PMID: 11504082

9

Safety, tolerability, and tumor response of IL4-Pseudomonas exotoxin (NBI-3001) in patients with recurrent malignant glioma.

Weber F, Asher A, Bucholz R, Berger M, Prados M, Chang S, Bruce J, Hall W, Rainov NG, Westphal M, Warnick RE, Rand RW, Floeth F, Rommel F, Pan H, Hingorani VN, Puri RK. Weber F, et al. J Neurooncol. 2003 Aug-Sep;64(1-2):125-37. doi: 10.1007/BF02700027. J Neurooncol. 2003. PMID: 12952293 Clinical Trial.

10

Imaging of gliomas with Cis-4-[18F]fluoro-L-proline.

Langen KJ, Jarosch M, Hamacher K, Mühlensiepen H, Weber F, Floeth F, Pauleit D, Herzog H, Coenen HH. Langen KJ, et al. Among authors: weber f. Nucl Med Biol. 2004 Jan;31(1):67-75. doi: 10.1016/s0969-8051(03)00121-5. Nucl Med Biol. 2004. PMID: 14741571 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,223 results

Search Page

Filters